Literature DB >> 10338120

Human platelets exclusively bind oxidized low density lipoprotein showing no specificity for acetylated low density lipoprotein.

I Volf1, T Moeslinger, J Cooper, W Schmid, E Koller.   

Abstract

The widely studied macrophage scavenger receptor system is known to bind both acetylated low density lipoprotein and oxidized low density lipoprotein. Although only the latter ligand has been shown to occur in vivo, acetylated low density lipoprotein is often used to evaluate the contribution of scavenger receptors to different (patho)physiologic processes, assuming that all existing subtypes of scavenger receptors recognise both lipoproteins. In the present work, we identify human platelets as the first natural cell type to bind oxidized low density lipoprotein without showing specificity for acetylated low density lipoprotein. Consequently, platelets possess exclusive receptor(s) for oxidized low density lipoprotein distinct from the 'classical' scavenger receptor AI/AII. From the data presented in this work, we conclude that the class B scavenger receptor CD36 (GPIV) is responsible for this exclusive oxidized low density lipoprotein binding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338120     DOI: 10.1016/s0014-5793(99)00437-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Surface expression of fatty acid translocase (FAT/CD36) on platelets in myeloproliferative disorders and non-insulin dependent diabetes mellitus: effect on arachidonic acid uptake.

Authors:  Hasib Salah-Uddin; Margaret J Gordon; Isobel Ford; Narendra N Tandon; Mike Greaves; Asim K Duttaroy
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

2.  Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.

Authors:  Roy L Silverstein
Journal:  Clin Lipidol       Date:  2009-12

3.  A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.

Authors:  Kan Chen; Maria Febbraio; Wei Li; Roy L Silverstein
Journal:  Circ Res       Date:  2008-05-22       Impact factor: 17.367

Review 4.  LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis.

Authors:  Aleksandra Gąsecka; Sylwester Rogula; Łukasz Szarpak; Krzysztof J Filipiak
Journal:  Life (Basel)       Date:  2021-01-11

5.  Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).

Authors:  Sigrun Badrnya; Alice Assinger; Ivo Volf
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

6.  Oxidized Low-Density Lipoprotein Induces Macrophage Production of Prothrombotic Microparticles.

Authors:  Julio F Marchini; Andre Manica; Paulo Crestani; Jochen Dutzmann; Eduardo J Folco; Heinz Weber; Peter Libby; Kevin Croce
Journal:  J Am Heart Assoc       Date:  2020-07-31       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.